BromocriptineBromocriptine reduces the level of the hormone prolactin by affecting the pituitary gland. It is sometimes used to treat conditions in which there is too much prolactin, such as certain forms of PMS and infertility. Theoretical Interference with Drug Action The herb chasteberry inhibits prolactin secretion and might have unpredictable effects if combined with bromocriptine.1–4 References►1. Milewicz A, et al. Vitex agnus-castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study. Arzneimittelforschung 43(7): 752–756, 1993. 2. Jarry H, et al. In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus-castus: Direct evidence for a dopaminergic principle by the dopamine receptor assay. EYP Clin Endocrinol 102: 448–454, 1994. 3. Sliutz G, et al. Agnus-castus extracts inhibit prolactin secretion of rat pituitary cells. Horm Metab Res 25(5): 253–255, 1993. 4. Schulz V, et al. Rational phytotherapy. New York: Springer-Verlag, 1998: 241–242. Last reviewed December 2015 by EBSCO CAM Review Board Last Updated: 12/15/2015 | |
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation. This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition. To send comments or feedback to our Editorial Team regarding the content please email us at healthlibrarysupport@ebsco.com. Our Health Library Support team will respond to your email request within 2 business days. | |